Stock & Company Details
Black Diamond Therapeutics Inc $BDTX
Price:
N/A
N/A
57M
$130M
52 Week High:
N/A
10 Day Average Volume:
N/A
-2.94
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
BDTX technical indicators
Latest Black Diamond Therapeutics Inc (BDTX) indicator readings as of 2026-08-28.
BDTX's 14-day RSI is 63.8, in neutral territory. At $2.23 it is trading 9.5% below its 200-day moving average of $2.46, and above its 50-day average of $1.91. Price sits in the middle of its Bollinger Bands ($1.74 to $2.38). ADX reads 34.6, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-189 and BDTX-1535.
Finance Bot
Ask your questions
Start by typing a question below.
